L
Lucira Health Inc
NASDAQ:LHDX
Lucira Health Inc
NASDAQ:LHDX
Price:
0.0339 USD
-19.29%
Updated:
Apr 25, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of LHDX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LHDX
Relative Value
Base Case
Not Available
L
Valuation Multiples
Multiples Across Competitors
LHDX Competitors Multiples
Lucira Health Inc Competitors
Lucira Health Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
L
|
Lucira Health Inc
NASDAQ:LHDX
|
1.4m USD | 0 | -0 | 0.1 | 0.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
185B USD | 4.6 | 32.9 | 19.4 | 28.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
130.9B USD | 17.9 | 65.8 | 54.5 | 67.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.8B USD | 6.2 | 40.4 | 25.2 | 31.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.3B USD | 3.3 | 25.1 | 13.4 | 19 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.7B USD | 3.4 | 54.7 | 18.4 | 38.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.4B EUR | 2.7 | 38.4 | 18.5 | 31.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.7B USD | 8.8 | 37.6 | 27.2 | 29.4 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
52.5B USD | 14.5 | 97 | 65.4 | 85.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
344.8B CNY | 10 | 30.4 | 26.4 | 26.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
